Relevant Links
Welcome To Protein Advances Inc.
Protein Advances Incorporated (Protein AI) is a biotechnology company with emphasis
on in silico and expert-systems assisted discovery. Protein
AI was founded in 2004 and now has the lab facilities,
the computational platforms, and the scientific expertise available to pursue a
bioinformatics-driven approach to vaccine and diagnostic discovery and development.
This includes antigens for a number of disease areas such as sleeping sickness
and leprosy and specific tools for clinical and field testing that are being developed
in collaboration with the Infectious Disease Research Institute. Recently, we
have developed a computational methodology that harnesses the power of cloud
computing to represent the proteome of a pathogenic organism by a small number
of peptide pools, a method we believe will enable rapid and economical screening of an entire
proteome and thereby provide a valuable utility in the quest for new diagnostic, vaccine, and
therapeutic targets. We're interested in setting up partnerships where our lab science and computational
expertise can help other organizations combat human disease.
New Lab and Office Space
We have moved. As part of our expansion to meet the needs of our new grants and contracts Protein AI is
delighted to announce its new lab and office space in Eklind Hall of the Seattle Life Sciences Center. To contact us now please use
our new
address.
This website includes certain statements, estimates and projections with respect to the anticipated future performance of Protein Advances Inc. Such statements, estimates or projections reflect various assumptions, which assumptions may or may not prove to be correct. No representations are made as to the accuracy of such statements, estimates or projections. The Company does not undertake any obligation to provide additional information or to update any of the information set forth in this web site.
© Copyright 2010 Protein Advances Inc.